Biostatistics



The mission of the Department of Biostatistics is to promote and enhance clinical and laboratory investigations through the creative application and further development of statistical science. Our highest priorities are the design of investigational protocols, analysis of protocol data, and reporting of protocol findings. Interim analyses of well-designed, well-executed studies facilitate the earliest safe use of effective new therapies, rapid dissemination of findings, and advancement of clinical research. A crucial component of our support is collaboration with bioinformaticists and molecular biologists to develop state-of-the-art statistical methods that can be used to extract meaningful information from genomic data. 

To ensure that investigators have access to uniformly high-quality, innovative statistical science for clinical trials design, we use an internal peer-review system. This process, which is sanctioned by the institution’s leadership, requires that all studies designed at St. Jude be reviewed and approved by the Protocol Review Committee (PRC) of the Department of Biostatistics.

The PRC consists of our faculty members, postdoctoral fellows and senior biostatisticians. In addition to clinical investigations, we are increasingly involved in the design of laboratory-based experiments, including genomic studies, and the analysis of data derived from such investigations.

We are the Operations and Biostatistics Center (OBC) for the NCI established Pediatric Brain Tumor Consortium (PBTC).

St. Jude's Biostatistics Department is chaired by James Boyett, PhD.


Email This Article Email This Article   |   Print Print